Your browser doesn't support javascript.
loading
Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions.
Gómez, Antonio; Pato, Miguel L; Bujanda, Luis; Sala, Núria; Companioni, Osmel; Cosme, Ángel; Tufano, Martina; Hanly, David J; García, Nadia; Sanz-Anquela, José Miguel; Gisbert, Javier P; López, Consuelo; Elizalde, José Ignacio; Cuatrecasas, Miriam; Andreu, Victoria; Paules, María José; Martín-Arranz, María Dolores; Ortega, Luis; Poves, Elvira; Barrio, Jesús; Torres, María Ángeles; Muñoz, Guillermo; Ferrández, Ángel; Ramírez-Lázaro, María José; Lario, Sergio; González, Carlos A; Esteller, Manel; Berdasco, María.
Afiliación
  • Gómez A; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), 08908 Barcelona, Spain.
  • Pato ML; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), 08908 Barcelona, Spain.
  • Bujanda L; Epigenetic Therapies Group, Experimental and Clinical Hematology Program (PHEC), Josep Carreras Leukaemia Research Institute, 08916 Barcelona, Spain.
  • Sala N; Department of Gastroenterology, Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco (UPV/EHU), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, 20014 San Sebastián, Spain.
  • Companioni O; Unit of Nutrition, Environment and Cancer, Institut Català d'Oncología, 08908 Barcelona, Spain.
  • Cosme Á; Translational Research Laboratory, Catalan Institute of Oncology (ICO)-IDIBELL, 08908 Barcelona, Spain.
  • Tufano M; Unit of Nutrition, Environment and Cancer, Institut Català d'Oncología, 08908 Barcelona, Spain.
  • Hanly DJ; Department of Gastroenterology, Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco (UPV/EHU), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, 20014 San Sebastián, Spain.
  • García N; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), 08908 Barcelona, Spain.
  • Sanz-Anquela JM; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Institute for Biomedical Research (IDIBELL), 08908 Barcelona, Spain.
  • Gisbert JP; Epigenetic Therapies Group, Experimental and Clinical Hematology Program (PHEC), Josep Carreras Leukaemia Research Institute, 08916 Barcelona, Spain.
  • López C; Unit of Nutrition, Environment and Cancer, Institut Català d'Oncología, 08908 Barcelona, Spain.
  • Elizalde JI; Translational Research Laboratory, Catalan Institute of Oncology (ICO)-IDIBELL, 08908 Barcelona, Spain.
  • Cuatrecasas M; Department of Pathology, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain.
  • Andreu V; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28006 Madrid, Spain.
  • Paules MJ; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28006 Madrid, Spain.
  • Martín-Arranz MD; Department of Gastroenterology, Hospital Clínic de Barcelona, IDIBAPS and CIBEREHD, 08036 Barcelona, Spain.
  • Ortega L; Department of Pathology, Hospital Clínic de Barcelona, IDIBAPS and CIBEREHD, 08036 Barcelona, Spain.
  • Poves E; Department of Gastroenterology, Hospital de Viladecans, 08840 Barcelona, Spain.
  • Barrio J; Department of Pathology, Hospital Universitari de Bellvitge, 08907 L'Hospitalet de Llobregat, Spain.
  • Torres MÁ; Department of Gastroenterology, Hospital Universitario La Paz, Instituto de Investigación Sanitaria La Paz (IdiPaz), 28046 Madrid, Spain.
  • Muñoz G; Department of Gastroenterology, Hospital Clínico San Carlos, 28040 Madrid, Spain.
  • Ferrández Á; Department of Gastroenterology, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain.
  • Ramírez-Lázaro MJ; Department of Gastroenterology, Hospital Universitario Río Hortega, 47012 Valladolid, Spain.
  • Lario S; Department of Pathology, Hospital Universitario Río Hortega, 47012 Valladolid, Spain.
  • González CA; Department of Gastroenterology, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
  • Esteller M; Department of Gastroenterology, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
  • Berdasco M; Department of Medicine, Digestive Diseases Service, Institut Universitari Parc Taulí, 08201 Sabadell, Spain.
Cancers (Basel) ; 13(11)2021 Jun 02.
Article en En | MEDLINE | ID: mdl-34199386
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article